Log In
BCIQ
Print this Print this
 

S-222611

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionDual inhibitor of epidermal growth factor (EGF) receptor (EGFR) and epidermal growth factor (EGF) receptor 2 (HER2; ErbB2; neu)
Molecular Target Epidermal growth factor receptor (EGFR) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor kinase inhibitor; Epidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today